Skip to main content


Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway

Fig. 2

The potential of cell-free DNA for noninvasive cancer management Plasma cell-free circulating tumor DNA (ctDNA) analysis shows promises for noninvasive molecular stratification, monitoring treatment responses and identifying genetic mechanisms of resistance to guide optimal treatment strategies

Back to article page